Human immuno-deficiency virus (HIV) disease

Clinical trials for Human immuno-deficiency virus (HIV) disease explained in plain language.

Never miss a new study

Get alerted when new Human immuno-deficiency virus (HIV) disease trials appear

Sign up with your email to follow new studies for Human immuno-deficiency virus (HIV) disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Can a drug combo let HIV patients ditch daily meds?

Disease control Stopped early

This study tested two experimental drugs, budigalimab and ABBV-382, in people with HIV who were stable on standard therapy. Participants stopped their usual HIV medications to see if the new drugs could keep the virus under control. The trial was terminated early, so it's unclear…

Matched conditions: HUMAN IMMUNO-DEFICIENCY VIRUS (HIV) DISEASE

Phase 2 • Sponsor: AbbVie • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC

Human immuno-deficiency virus (HIV) disease

Get alerted when new Human immuno-deficiency virus (HIV) disease trials appear

Can a drug combo let HIV patients ditch daily meds?